Refractory PR3-positive ANCA-associated vasculitis with eosinophilia requiring anti-IL-5 therapy: A case report
Modern Rheumatology Case Reports · 2023
DOI: 10.1093/mrcr/rxac096 ↗Kurz gefasst
Fallbericht in der Zeitschrift Modern Rheumatology Case Reports, 2023. Verfasst von Elizabeth Anderson und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Oregon Health & Science University, Portland, OR, USA. Hauptthemen laut MEDLINE: Granulomatosis with Polyangiitis, Churg-Strauss Syndrome, Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis, Eosinophilia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 14 Literaturangaben. Gefördert von: NCATS NIH HHS, Oregon Health & Science University Wheels Up Award NIH NCATS.
Abstract (Originalsprache)
This report describes a highly unusual and refractory case of proteinase-3–positive antineutrophil cytoplasmic autoantibody–associated vasculitis, which was associated with marked eosinophilia and only achieved remission after interleukin-5 blockade was added to maximal induction therapy. The patient was a healthy 18-year-old woman who presented with scleritis, otitis, constitutional symptoms, skin and mucosal lesions, and diffuse alveolar haemorrhage and found to have refractory eosinophilia of unclear aetiology. The case did not meet classification criteria for a diagnosis of granulomatosis with polyangiitis or eosinophilic granulomatosis with polyangiitis. Despite induction therapy with glucocorticoids, cyclophosphamide, and rituximab, she did not achieve remission or normalisation of eosinophilia until the addition of mepolizumab, which corresponded to the suppression of peripheral blood eosinophils and clinical remission. This case highlights the limitations of classification criteria and success of interleukin-5 in a multimodal treatment of severe vasculitis with eosinophilia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Oregon Health & Science University, Portland, OR, USA.
- Division of Arthritis and Rheumatic Diseases, School of Medicine, Oregon Health & Science University, Portland, OR, USA.
ORCID-Profile: Elizabeth Anderson
Förderung
- NCATS NIH HHS
- Oregon Health & Science University Wheels Up Award NIH NCATS
Zitieren
APA
Anderson, E., & Friedman, M. A. (2023). Refractory PR3-positive ANCA-associated vasculitis with eosinophilia requiring anti-IL-5 therapy: A case report. Modern Rheumatology Case Reports. https://doi.org/10.1093/mrcr/rxac096
Vancouver
Anderson E, Friedman MA. Refractory PR3-positive ANCA-associated vasculitis with eosinophilia requiring anti-IL-5 therapy: A case report. Modern Rheumatology Case Reports. 2023. doi:10.1093/mrcr/rxac096
BibTeX
@article{Anderson2023,
author = {Anderson, Elizabeth and Friedman, Marcia A},
title = {Refractory PR3-positive ANCA-associated vasculitis with eosinophilia requiring anti-IL-5 therapy: A case report},
journal = {Modern Rheumatology Case Reports},
year = {2023},
doi = {10.1093/mrcr/rxac096}
}
EUVIMED